JSK Biomed and Fotona d.o.o. Forge Global Partnership

On July 23, JSK Biomed signed a global distribution agreement with Fotona d.o.o and held a signing ceremony to commemorate the event.

The ceremony marked the beginning of a global partnership between JSK Biomed and Fotona d.o.o., aiming to share their vision and strategies for leading the medical device market. In attendance were Matjaz Lukac, Chairman of Fotona d.o.o., and Dr. Jan Bogataj, Fotona KOL (Key Opinion Leader), who visited Korea in person to underscore the significance of the partnership and outline future plans.

Under this agreement, JSK Biomed has granted Fotona d.o.o. global distribution rights. Fotona d.o.o. will configure the products for optimal integration with its laser devices and distribute them across Europe, North America, Asia, and other regions through its global sales network. 

This strategic alliance enables JSK Biomed to leverage Fotona's well-established supply chain, facilitating swift market entry and efficient outreach not only to new buyers but also to hospitals and clinics that already own Fotona devices. Fotona d.o.o, in turn, aims to move beyond its traditional single-sale equipment model to establish a recurring revenue system through consumable products, generating tangible synergy for both companies.

CEO Jinwoo Jeon of JSK Biomed stated, “JSK Biomed has set a new standard in the medical device market with our innovative product, MiraJet. Now, by partnering with Fotona d.o.o., we aim to solidify our presence in the global market. I hope today marks the beginning of a new chapter of success for both companies, and I ask for your continued support and encouragement going forward.”

Chairman Matjaz Lukac of Fotona d.o.o. emphasized, “This partnership has been designed to create powerful synergy by combining both companies' global networks, clinical expertise, and technological capabilities. The areas we are set to explore include not only innovation in non-invasive medical devices but also a shift in therapeutic paradigms.” And he added, “MiraJet is more than just a product—it holds remarkable potential to redefine treatment approaches and user experiences. I hope this collaboration becomes a model of sustainable cooperation that truly enhances patients’ quality of life.”

Following the speeches, the two companies held the official contract signing and shared their joint vision. They pledged to set a new standard in medical technology and contribute to improving patient quality of life worldwide through responsible, ethical, and sustainable cooperation in the global healthcare sector.

Meanwhile, Fotona d.o.o launched the world’s first Variable Square Pulse (VSP) Er:YAG laser system in 1993. It currently possesses a global distribution network spanning over 70 countries, offering high-performance medical devices based on Er:YAG and Nd:YAG dual-wavelength technology. With over 20,000 systems in use globally, Fotona d.o.o. continues to maintain its brand credibility through collaborative research and academic activity with KOLs. The company holds a leading position in the global medical aesthetics industry in terms of technological superiority and clinical scalability.